BMC - Molecular and Cell Biomedicine

Group type R+D+I Group ( Generic )
AEI areas Biomedicine (BME)
2030 Goals and Targets
  • Health and well-being
    • Goal 3 - Target 4 @ Reduce mortality from non-communicable diseases
Areas
  • Lipid-based therapy research and development for neurological and oncological diseases
  • Research into the plant pathology of neurological and oncological diseases for therapeutic purposes
  • Studies into the biophysical and biochemical properties of cell membranes based on lipid composition
Research team
Principal investigators
Dr Torres Canalejo, Manuel (University Professor)
Members
  • Dr Busquets Xaubet, Xavier (University Professor)
  • Dr Casares de la Rosa, Doralicia (Collaborating Researcher of the UIB)
  • Montaner Cubi, Juan Carlos
  • Dr Rosselló Castillo, Catalina Ana (Associate Professor)
  • Dr Beteta Gobel, Roberto (Associate Professor)
  • Dr FERNANDEZ GARCIA, PAULA
  • Dr Rodríguez Lorca, Raquel (Collaborating Researcher of the UIB)
  • Dr Román Roldán, Ramón (UIB Collaborating Researcher)
  • Dr Salvador Castell, Marta (Collaborating Researcher of the UIB)
  • Montero Cabrera, Ana Alicia (Collaborating Researcher of the UIB)
Financed by, logos